Liang Zhang1, Greg M Thurber2,3. 1. Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA. 2. Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA. gthurber@umich.edu. 3. Department of Biomedical Engineering, University of Michigan, 2800 Plymouth Rd., Ann Arbor, MI, 48109, USA. gthurber@umich.edu.
Abstract
PURPOSE: Quantitative molecular imaging of beta cell mass (BCM) would enable early detection and treatment monitoring of type 1 diabetes. The glucagon-like peptide-1 (GLP-1) receptor is an attractive target due to its beta cell specificity and cell surface location. We quantitatively investigated the impact of plasma clearance and receptor internalization on targeting efficiency in healthy B6 mice. PROCEDURES: Four exenatide-based probes were synthesized that varied in molecular weight, binding affinity, and plasma clearance. The GLP-1 receptor internalization rate and in vivo receptor expression were quantified. RESULTS: Receptor internalization (54,000 receptors/cell in vivo) decreased significantly within minutes, reducing the benefit of a slower-clearing agent. The multimers and albumin binding probes had higher kidney and liver uptake, respectively. CONCLUSIONS: Slow plasma clearance is beneficial for GLP-1 receptor peptide therapeutics. However, for exendin-based imaging of islets, down-regulation of the GLP-1 receptor and non-specific background uptake result in a higher target-to-background ratio for fast-clearing agents.
PURPOSE: Quantitative molecular imaging of beta cell mass (BCM) would enable early detection and treatment monitoring of type 1 diabetes. The glucagon-like peptide-1 (GLP-1) receptor is an attractive target due to its beta cell specificity and cell surface location. We quantitatively investigated the impact of plasma clearance and receptor internalization on targeting efficiency in healthy B6 mice. PROCEDURES: Four exenatide-based probes were synthesized that varied in molecular weight, binding affinity, and plasma clearance. The GLP-1 receptor internalization rate and in vivo receptor expression were quantified. RESULTS: Receptor internalization (54,000 receptors/cell in vivo) decreased significantly within minutes, reducing the benefit of a slower-clearing agent. The multimers and albumin binding probes had higher kidney and liver uptake, respectively. CONCLUSIONS: Slow plasma clearance is beneficial for GLP-1 receptor peptide therapeutics. However, for exendin-based imaging of islets, down-regulation of the GLP-1 receptor and non-specific background uptake result in a higher target-to-background ratio for fast-clearing agents.
Entities:
Keywords:
Exendin; Glucagon-like peptide-1 receptor; Type 1 diabetes imaging
Authors: Charles Pyke; R Scott Heller; Rikke K Kirk; Cathrine Ørskov; Steffen Reedtz-Runge; Peter Kaastrup; Anders Hvelplund; Linda Bardram; Dan Calatayud; Lotte Bjerre Knudsen Journal: Endocrinology Date: 2014-01-27 Impact factor: 4.736
Authors: Yoshifumi Saisho; Alexandra E Butler; Erica Manesso; David Elashoff; Robert A Rizza; Peter C Butler Journal: Diabetes Care Date: 2012-08-08 Impact factor: 19.112
Authors: Erik Vegt; Marleen Melis; Annemarie Eek; Monique de Visser; Maarten Brom; Wim J G Oyen; Martin Gotthardt; Marion de Jong; Otto C Boerman Journal: Eur J Nucl Med Mol Imaging Date: 2010-12-18 Impact factor: 9.236
Authors: Liang Zhang; Yuzhen Wang; Kristoff T Homan; Stephanie M Gaudette; Andrew J McCluskey; Ying Chan; Joanne Murphy; Mary Abdalla; Christine M Nelson; Victor Z Sun; Jamie E Erickson; Heather L Knight; Anca Clabbers; Annette J Schwartz Sterman; Soumya Mitra Journal: Mol Imaging Biol Date: 2022-07-29 Impact factor: 3.484
Authors: Ian Nessler; Eshita Khera; Steven Vance; Anna Kopp; Qifeng Qiu; Thomas A Keating; Adnan O Abu-Yousif; Thomas Sandal; James Legg; Lorraine Thompson; Normann Goodwin; Greg M Thurber Journal: Cancer Res Date: 2020-01-15 Impact factor: 12.701
Authors: Ahmed Abbas; Christine Beamish; Rebecca McGirr; John Demarco; Neil Cockburn; Dawid Krokowski; Ting-Yim Lee; Michael Kovacs; Maria Hatzoglou; Savita Dhanvantari Journal: F1000Res Date: 2016-07-27